Neuroplasticity in an Extended Amygdala Network as a Target Mechanism for Attention Bias Modification Outcome
2 other identifiers
interventional
119
1 country
1
Brief Summary
Anxiety disorders are one of the most common psychological disorders. Underlying anxiety is an increased attentional bias to threat, which has been identified as a causal contributor in the development of anxiety. Given this causal relationship, attention bias modification was introduced as a treatment option where anxiety is reduced by training individuals to direct their attention away from threat and thereby decreasing anxiety. Over a decade of research using this approach, called attention bias modification (ABM), suggests that overall the approach is effective in reducing anxiety. Although ABM appears to be a very promising treatment option for anxiety, there are several factors limiting the effectiveness of ABM. These include the recognition of individual-level needs and a known underlying mechanism of action by which ABM is effective. Neuroimaging evidence suggests that attentional bias to visual threat is associated with a network of brain regions including the amygdala, anterior cingulate cortex, and visual cortex. In human participants, experience-dependent neuroplasticity is visible in voxel-based morphometry based measures of gray matter volume following training. Recently, voxel-based morphometry measures of gray matter volume have been linked to dendritic spine density-a known cellular mechanism for learning-related neuroplasticity. Thus, voxel-based morphometry measures are ideally suited to measure learning-related neuroplasticity following attention bias modification. In this proposal participants' level of attentional bias, anxiety, and gray matter volume will be measured before and after completing six weeks of attention bias modification training (N = 50) or attention control training (N= 50). The proposal aims to (1) establish that pre-treatment bias predicts variability in gray matter volume in the extended amygdala and anterior cingulate cortex, (2) assess the extent to which reduced extended amygdala and anterior cingulate cortex gray matter volume following ABM underlies reductions in attentional bias and anxiety, and (3) Establish pre-treatment bias as a predictor of successful ABM as measured by reduced bias, reduced anxiety, and reduced gray matter volume in the extended amygdala and anterior cingulate cortex. Consistent with the objectives of the AREA grant and NIMH's focus on identifying and validating new targets for treatment development that underlie disease mechanisms, the current proposal plans to involve students at a rural primarily undergraduate university in a research project aimed at establishing neuroplasticity in the extended amygdala and anterior cingulate cortex as a target mechanism for ABM training outcome, which could be used to objectively track training-related outcomes in anxiety treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Dec 2017
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2017
CompletedFirst Posted
Study publicly available on registry
March 28, 2017
CompletedStudy Start
First participant enrolled
December 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2020
CompletedJanuary 12, 2022
January 1, 2022
2.2 years
March 14, 2017
January 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Attentional Bias
Reaction time difference to congruent and incongruent trials in the dot-probe task, which measure heightened attentional bias to threat.
Baseline and after 6 weeks of the intervention
Secondary Outcomes (1)
State and Trait Anxiety
Baseline and after 6 weeks of the intervention
Other Outcomes (2)
MRI measures of gray matter volume
Baseline and after 6 weeks of the intervention
MRI measures of structural and functional connectivity
Baseline and after 6 weeks of the intervention
Study Arms (2)
Attention Bias Modification
EXPERIMENTALAttention Control
ACTIVE COMPARATORInterventions
Attention bias modification (ABM) sessions will consist of a modified dot-probe task that only contains incongruent trials (i.e., target-dot - neutral stimulus 100% pairing).
Attention control (AC) sessions, will consist of a standard dot-probe task (i.e., target-dot - neutral/threat stimulus 50% pairing). Thus, for AC participants, bias should remain the same, while ABM participants should show a reduced bias to threat.
Eligibility Criteria
You may qualify if:
- Handedness (right handed)
- Normal Vision
- High Anxiety
- Preexisting Attentional Bias
You may not qualify if:
- No MRI contraindications
- No History of Head Injury
- No Neurological History
- Psychological History
- Limited Recreational Drug Use, No Abuse
- Limited Prescription Drug Use, No Abuse
- No Claustrophobia
- Not Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northern Michigan University
Marquette, Michigan, 49855, United States
Related Publications (2)
Carlson JM, Fang L, Koster EHW, Andrzejewski JA, Gilbertson H, Elwell KA, Zuidema TR. Neuroplastic changes in anterior cingulate cortex gray matter volume and functional connectivity following attention bias modification in high trait anxious individuals. Biol Psychol. 2022 Jul;172:108353. doi: 10.1016/j.biopsycho.2022.108353. Epub 2022 May 13.
PMID: 35569575DERIVEDCarlson JM, Fang L. Attentional bias to threat and gray matter volume morphology in high anxious individuals. Cogn Affect Behav Neurosci. 2022 Jun;22(3):600-609. doi: 10.3758/s13415-021-00968-9. Epub 2021 Nov 9.
PMID: 34755317DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joshua M Carlson, PhD
Northern Michigan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2017
First Posted
March 28, 2017
Study Start
December 15, 2017
Primary Completion
March 14, 2020
Study Completion
March 14, 2020
Last Updated
January 12, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
Data will be uploaded to the NIMH Data Archive